Cassava Sciences, Inc. (SAVA)
NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous close | 43.07 |
| Open | 42.63 |
| Bid | 41.80 x 1000 |
| Ask | 42.29 x 1000 |
| Day's range | 41.09 - 44.78 |
| 52-week range | 13.84 - 100.00 |
| Volume | |
| Avg. volume | 3,650,982 |
| Market cap | 1.677B |
| Beta (5Y monthly) | 0.52 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -1.16 |
| Earnings date | 08 Nov 2022 - 14 Nov 2022 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | 13 Dec 2012 |
| 1y target est | 69.00 |
- Zacks
Cassava Sciences, Inc. (SAVA) Stock Moves -1.76%: What You Should Know
Cassava Sciences, Inc. (SAVA) closed the most recent trading day at $43.07, moving -1.76% from the previous trading session.
- Zacks
Cassava Sciences, Inc. (SAVA) Dips More Than Broader Markets: What You Should Know
Cassava Sciences, Inc. (SAVA) closed the most recent trading day at $31.04, moving -1.71% from the previous trading session.
- GlobeNewswire
Cassava Sciences to Present at the H.C. Wainwright Global Investment Conference
AUSTIN, Texas, Sept. 08, 2022 (GLOBE NEWSWIRE) -- Cassava Sciences, Inc. (Nasdaq: SAVA), a clinical-stage biotechnology company focused on Alzheimer’s disease, announced today that it has been invited to present a corporate overview at the H.C. Wainwright 24th Annual Global Investment Conference, being held in New York. Remi Barbier, President & CEO, will participate in-person at this corporate event. Institutional investors who are registered for this conference may log into www.hcwevents.com t
© 2022 Yahoo. All rights reserved.
